Rafael J Tamargo Selected Research

Carotid Endarterectomy

9/2016	Is Carotid Revascularization Safe for Patients with Concomitant Carotid Stenosis and Intracranial Aneurysms?
5/2016	Risk Factors Associated with Ipsilateral Ischemic Events Following Carotid Endarterectomy for Carotid Artery Stenosis.
5/2016	Restenosis After Carotid Endarterectomy: Insight Into Risk Factors and Modification of Postoperative Management.
6/2006	Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy.
11/2005	3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rafael J Tamargo Research Topics

Disease

34	Aneurysm (Aneurysms) 08/2023 - 06/2002
27	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 07/2023 - 06/2002
16	Stroke (Strokes) 04/2024 - 11/2005
13	Intracranial Aneurysm (Cerebral Aneurysm) 01/2022 - 05/2005
12	Hemorrhage 09/2023 - 11/2002
12	Thrombosis (Thrombus) 01/2022 - 09/2006
11	Intracranial Vasospasm 03/2012 - 11/2002
8	Neoplasms (Cancer) 12/2018 - 06/2002
7	Inflammation (Inflammations) 03/2012 - 08/2003
5	Rupture 07/2023 - 10/2014
5	Hydrocephalus (Hydrocephaly) 07/2023 - 04/2010
4	Brain Ischemia (Cerebral Ischemia) 09/2023 - 04/2003
3	Ischemic Stroke 08/2023 - 04/2014
3	Infarction (Infarctions) 05/2023 - 04/2003
3	Hematoma 01/2023 - 09/2006
3	Carotid Stenosis (Carotid Artery Stenosis) 09/2016 - 05/2016
3	Transient Ischemic Attack 05/2016 - 11/2005
3	Seizures (Absence Seizure) 03/2016 - 02/2002
3	Hypertension (High Blood Pressure) 01/2013 - 01/2007
3	Hyperglycemia 05/2010 - 06/2006
2	Moyamoya Disease (Moya-Moya Disease) 04/2024 - 02/2018
2	Subdural Hematoma (Subdural Hemorrhage) 10/2023 - 11/2018
2	Hypothermia 09/2023 - 04/2003
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2023 - 01/2023
2	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 08/2007
2	Cerebrospinal Fluid Rhinorrhea 01/2021 - 08/2007
2	Pathologic Constriction (Stenosis) 11/2018 - 01/2013
2	Headache (Headaches) 11/2016 - 04/2015
2	Arteriovenous Malformations (Arteriovenous Malformation) 03/2016 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2015 - 10/2006
2	Paralysis (Palsy) 08/2012 - 06/2007
2	Fistula 01/2012 - 12/2009
2	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 01/2012 - 12/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2006 - 04/2003
2	Radiculopathy (Radiculopathy, Cervical) 02/2004 - 08/2002
1	Fibrosis (Cirrhosis) 10/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2023
1	Infections 09/2023
1	Ulcer 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023
1	Pulmonary Embolism 01/2023
1	Shock 01/2023
1	Sepsis (Septicemia) 01/2023
1	Venous Thromboembolism 01/2023
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Meningioma (Meningiomas) 01/2022
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021
1	Deglutition Disorders (Dysphagia) 01/2020

Drug/Important Bio-Agent (IBA)

9	HaptoglobinsIBA 01/2019 - 12/2007
7	PolymersIBA 09/2006 - 02/2002
4	Abciximab (ReoPro)FDA Link 10/2018 - 10/2017
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2012 - 11/2002
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2006 - 04/2003
3	Hemoglobins (Hemoglobin)IBA 04/2024 - 08/2003
3	Glucose (Dextrose)FDA LinkGeneric 05/2010 - 06/2006
3	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 05/2006 - 11/2002
3	Nitric Oxide DonorsIBA 10/2005 - 11/2002
3	Ibuprofen (Motrin)FDA LinkGeneric 07/2005 - 04/2003
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2023 - 09/2006
2	Indicators and Reagents (Reagents)IBA 01/2023 - 06/2007
2	Bone Cements (Bone Glue)IBA 01/2021 - 08/2007
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
2	Cocaine (Cocaine HCl)IBA 03/2016 - 07/2013
2	hydroxyapatite cementIBA 04/2015 - 08/2007
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 11/2006
2	EnzymesIBA 09/2012 - 07/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2009 - 11/2005
2	Simvastatin (Zocor)FDA LinkGeneric 05/2009 - 05/2006
2	Cell Adhesion MoleculesIBA 09/2006 - 07/2005
2	Oxidoreductases (Dehydrogenase)IBA 05/2006 - 11/2005
2	Monoclonal AntibodiesIBA 07/2004 - 08/2003
1	Oxygen (Dioxygen)IBA 09/2023
1	calcium phosphateIBA 01/2021

Therapy/Procedure

20	Craniotomy 01/2022 - 06/2002
12	Therapeutics 02/2022 - 07/2004
10	Length of Stay 04/2024 - 08/2012
10	Stents 07/2019 - 03/2012
9	Conservative Treatment 08/2023 - 08/2002
9	Catheters 04/2018 - 10/2006
7	Surgical Instruments (Clip) 02/2022 - 06/2002
6	Aftercare (After-Treatment) 12/2022 - 03/2012
5	Carotid Endarterectomy 09/2016 - 11/2005
4	Thrombectomy 09/2023 - 01/2022
3	Laminectomy 07/2015 - 02/2004
3	Critical Care (Surgical Intensive Care) 06/2015 - 06/2002
2	Punctures 05/2023 - 11/2010
2	Cerebral Revascularization 01/2023 - 04/2010
2	Neurosurgical Procedures 01/2023 - 04/2003
2	Salvage Therapy 10/2018 - 01/2018
1	Continuous Renal Replacement Therapy 10/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2023
1	Renal Dialysis (Hemodialysis) 10/2023
1	Retreatment 07/2023
1	Mechanical Ventilators (Ventilator) 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Chemoprevention 01/2023
1	Reoperation 01/2021
1	Gastrostomy 01/2020